These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 2585826
1. [Comparative studies of clinicopathological findings in patients with adult and juvenile onset of IgA nephropathy]. Yaguchi Y, Tomino Y, Nakamura T, Funabiki K, Shirato I, Ebiiiara I, Nakayama S, Koide H. Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):729-33. PubMed ID: 2585826 [Abstract] [Full Text] [Related]
2. [Clinicopathological study on IgA nephritis]. Akimoto M. Nihon Jinzo Gakkai Shi; 1989 Jan; 31(1):77-90. PubMed ID: 2747002 [Abstract] [Full Text] [Related]
3. [Discriminant analysis of clinical markers before renal biopsy in patients with IgA nephropathy]. Yagame M. Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):735-42. PubMed ID: 2585827 [Abstract] [Full Text] [Related]
4. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function. Moriyama T, Honda K, Nitta K, Yumura W, Nihei H. Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901 [Abstract] [Full Text] [Related]
5. IgA nephropathy in patients over 50 years of age: a multicentre, prospective study. Frimat L, Hestin D, Aymard B, Mayeux D, Renoult E, Kessler M. Nephrol Dial Transplant; 1996 Jun; 11(6):1043-7. PubMed ID: 8671966 [Abstract] [Full Text] [Related]
6. [Importance of the duration from the onset of a urinary abnormality until a biopsy is performed: a multivariate analysis on the application of renal biopsy for patients with IgA nephropathy]. Kiyoshi Y, Hisano S, Takebayashi S. Nihon Jinzo Gakkai Shi; 1998 Sep; 40(7):547-54. PubMed ID: 9805921 [Abstract] [Full Text] [Related]
7. Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation. Kennoki T, Ishida H, Yamaguchi Y, Tanabe K. Transplantation; 2009 Oct 15; 88(7):935-41. PubMed ID: 19935466 [Abstract] [Full Text] [Related]
8. [Severe proteinuria in IgA nephropathy. Clinicopathological study of 8 cases with 100 serial sections]. Shouno Y, Shimokama T, Sakemi T, Harada A, Watanabe T. Nihon Jinzo Gakkai Shi; 1993 Sep 15; 35(9):1043-50. PubMed ID: 8230814 [Abstract] [Full Text] [Related]
9. Differences in new-onset IgA nephropathy between young adults and the elderly. Wen YK, Chen ML. Ren Fail; 2010 Jan 15; 32(3):343-8. PubMed ID: 20370450 [Abstract] [Full Text] [Related]
10. Henoch-Schoenlein nephritis and IgA nephropathy in children: a comparison of clinical course. Yoshikawa N, Ito H, Yoshiya K, Nakahara C, Yoshiara S, Hasegawa O, Matsuyama S, Matsuo T. Clin Nephrol; 1987 May 15; 27(5):233-7. PubMed ID: 3594938 [Abstract] [Full Text] [Related]
11. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients. Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS. Singapore Med J; 2008 Nov 15; 49(11):924-9. PubMed ID: 19037561 [Abstract] [Full Text] [Related]
12. Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy? Lai KN, Ho CP, Chan KW, Yan KW, Lai FM, Vallance-Owen J. Q J Med; 1985 Oct 15; 57(222):677-88. PubMed ID: 4080957 [Abstract] [Full Text] [Related]
13. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria. Hwang HS, Kim BS, Shin YS, Yoon HE, Song JC, Choi BS, Park CW, Yang CW, Kim YS, Bang BK. Nephrology (Carlton); 2010 Mar 15; 15(2):236-41. PubMed ID: 20470285 [Abstract] [Full Text] [Related]
14. [Effect of plasma exchange therapy on IgA nephropathy in children--a retrospective study]. Tsunoda Y. Nihon Jinzo Gakkai Shi; 1995 Apr 15; 37(4):238-46. PubMed ID: 7602811 [Abstract] [Full Text] [Related]
15. Can immunosuppressive drugs slow the progression of IgA nephropathy? Goumenos D, Ahuja M, Shortland JR, Brown CB. Nephrol Dial Transplant; 1995 Apr 15; 10(7):1173-81. PubMed ID: 7478120 [Abstract] [Full Text] [Related]
16. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy. Okada H, Suzuki H, Konishi K, Sakaguchi H, Saruta T. Clin Nephrol; 1992 May 15; 37(5):235-8. PubMed ID: 1606773 [Abstract] [Full Text] [Related]
17. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study. Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC, HKVIN Study Group. Am J Kidney Dis; 2006 May 15; 47(5):751-60. PubMed ID: 16632013 [Abstract] [Full Text] [Related]
18. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study. Weber CL, Rose CL, Magil AB. Nephrol Dial Transplant; 2009 Feb 15; 24(2):483-8. PubMed ID: 18786972 [Abstract] [Full Text] [Related]
19. The renin--angiotensin system gene polymorphisms and clinicopathological correlations in IgA nephropathy. Ong-Ajyooth S, Ong-Ajyooth L, Limmongkon A, Tiensingh A, Parichatikanon P, Nilwarangkur S. J Med Assoc Thai; 1999 Jul 15; 82(7):681-9. PubMed ID: 10511770 [Abstract] [Full Text] [Related]
20. Repeat renal biopsy in children with IgA nephropathy. Yoshikawa N, Iijima K, Matsuyama S, Suzuki J, Kameda A, Okada S, Nakamura H. Clin Nephrol; 1990 Apr 15; 33(4):160-7. PubMed ID: 2190720 [Abstract] [Full Text] [Related] Page: [Next] [New Search]